Phase 3 Trial Shows Intravenous Immune Globulin Effective for Dermatomyositis
Patients saw improvements in the first-ever phase 3 trial of the blood therapy for the condition.
Best Treatment Options for Patients with Eczema
Peter Lio, MD, talks about the difficulties and strategies used when treating patients with this common skin disorder.
New Data Indicates SilverSeal Hydrogel Dressing Successful in Treating Postsurgical Scars
NEXGEL’s dressing demonstrates significant scar improvement as early as 6 weeks after surgery.
Exploring the Relationship Between Psoriatic Arthritis and Psoriasis
Two expert dermatologists discuss the relationship between PsA and PsO in this DermView series recap.
Study Reveals Psoriasis Drug May Have Cardiometabolic Benefits in Patients with Psoriatic Disease
New research finds psoriasis drug apremilast could help patients lose weight.
FDA Approves Dupliumab for Prurigo Nodularis
Sanofi and Regeneron’s dupliumab will provide relief to patients with extreme itch and skin lesions.
Ruxolitinib Cream Rapidly Reduced Itch for Atopic Dermatitis in Phase 3 Study
Recent study results demonstrated a noticeable reduction in itch just 12 hours after application of ruxolitinib.
CHMP Recommends Use of Adtralza (tralokinumab) to Treat Adolescents with Moderate-to-Severe AD
The CHMP's recommendations are based on data from a phase 3 ECZTRA 6 trial in adolescents with moderate-to-severe AD cases.
New Device Offers Added Hope in Patients with Skin of Color
Aerolase launches the Exci308 to help fight common skin conditions.
Doctor Provides Overview on Assessing Vitiligo at EADV 2022
Medical experts use common set of criteria to diagnose disease.
Relationship Between BCC and Transplant Patients Analyzed at EADV Congress
The relationship between transplant patients and basal cell carcinoma was discussed at EADV Congress 2022 in Milan, Italy.
New Study Finds Skin Immune Biomarker Test Helps Predict Eczema in Babies
New sticky tape study can help predict onset of pediatric atopic eczema in babies.
Arcutis to Present Data Fom Topical Roflumilast Clinical Program at EADV 2022 Congress
Arcutis to present data from topical roflumilast clinical program at EADV 2022 Congress.
Enrollment Milestone Achieved in Phase 3 Clinical Trials for DFD-29 Treatment of PPR
Topline data expected in the first half of 2023.
New Research Finds Shared Decision-Making Beneficial in Care of Patients With Eczema
New research by the National Eczema Association has revealed the importance of patient input into treatment decisions.
2 Clarke Drive Cranbury, NJ 08512